ľֱ

Endocrinology

Type 1 Diabetes

More in Type 1 Diabetes

Thyroid Drug & Bone Loss; GLP-1s' Renal Benefit; Menopause Musculoskeletal Syndrome

News and commentary from the endocrinology world

Nov 26, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
CGM Uptake Very Low for Vulnerable Diabetes Populations

But how to achieve equitable use remains "complicated," says expert

Nov 22, 2024
A photo of a woman taking a reading with her continuous glucose monitor.
75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data?

News and commentary from the endocrinology world

Nov 19, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Extended Dosing Intervals Possible With Aflibercept in Diabetic Macular Edema

In the third year, 88% of patients could go 12 weeks or longer with 8-mg dose

Nov 18, 2024
image
16% of Adults Have Diabetes; Compounded Semaglutide Deaths; Testosterone Tx Surge

News and commentary from the endocrinology world

Nov 12, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Slow Start for AI-Assisted Screening for Diabetic Retinopathy Despite Promise

Ophthalmologists hope expanded use will lead to more evaluations in primary clinics

Nov 08, 2024
A photo of diabetic retinopathy.
CGM OK'd During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Down

News and commentary from the endocrinology world

Nov 05, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
FDA Panel Rejects SGLT1/2 Inhibitor for Type 1 Diabetes

Data too uncertain to support sotagliflozin in subset with chronic kidney disease, advisors say

Nov 01, 2024
FDA ADCOMM sotagliflozin over a computer rendering of chronic kidney disease.
FDA Staff Not Quite Sold on Sotagliflozin for T1D Patients With CKD

SGLT1/SGLT2 inhibitor has another shot in T1D, but now in more narrow patient population

Oct 30, 2024
FDA ADCOMM sotagliflozin over a computer rendering of chronic kidney disease.
Scripts for GLP-1, SGLT2 Drugs on the Rise in Type 1 Diabetes Patients

Findings leave researcher "concerned"

Oct 23, 2024
A photo of a woman holding out a semaglutide injection pen.
Acromegaly Injectable Rejected; Nobel Prize Winner Dies; Obesity Doubles in Kids

News and commentary from the endocrinology world

Oct 22, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Serious Battery Issue Prompts Medtronic Insulin Pump Recall

Problem linked to 170 reports of hyperglycemia and 11 ketoacidosis cases

Oct 18, 2024
A photo of a man holding a Medtronic MiniMed 780G pump.
Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1D

News and commentary from the endocrinology world

Oct 01, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Former NFL QB's Dementia; Stem Cells Reverse Woman's Diabetes; More Free COVID Tests

Health news and commentary gathered by ľֱ staff

Sep 27, 2024
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.
More in Type 1 Diabetes

0.50 CME Credits
Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes

0.75 CME Credits
Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care

0.25 CME Credits
Applying the Latest Evidence to Overcome Endocrine Resistance in HR+/HER2- Breast Cancer

0.50 CME Credits
Examining the Pathophysiology, Burden, and Evolving Treatment Landscape of Acromegaly

0.50 CME Credits
Enhancing Acromegaly Care Through Integration of the Latest Clinical Evidence and Patient-Centered Management

0.50 CME Credits
Cutting-Edge Treatment Approaches for Patients With T1D and Impaired Awareness of Hypoglycemia (IAH)

0.50 CME Credits
Breakthroughs in Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome Management: Key Findings From ACC 2024

1.00 CME Credits
Navigating Cardiovascular Risk: The Critical Role of Lipoprotein(a) Screening and Treatment